Stocks of the Hour: Imugene, RocketDNA, Marquee Resources
Stocks of the Hour: Imugene, RocketDNA, Marquee Resources
Imugene (ASX:IMU) announced promising results from its Phase 1b clinical trial with azer-cel, in patients with relapsed/refractory diffuse large B cell lymphoma. All enrolled patients had cancer that had returned following autologous CAR T therapy, a high unmet need for this patient population. Shares are trading 25.81 per cent higher at 7.8 cents.
Imugene（ASX:IMU）宣布其azer-cel用于难治性/复发性弥漫性大B细胞淋巴瘤的第十亿临床试验取得了令人满意的结果。所有入组患者均患有随后进行自体CAR t疗法治疗后复发的癌症，这对于该患者群体有着很高的未被满足的需求。股价上涨25.81%，报0.078美元。
RocketDNA (ASX:RKT) has secured two new contracts for autonomous PatrolBot surveillance solutions. PatrolBot is a security-specific model of the xBot solution series, providing autonomous perimeter monitoring and surveillance, ensuring the safety of critical infrastructure and assets. The total contract value (TCV) of ~AU$350,000. Shares are trading 22.22 per cent higher at 1.1 cents.
RocketDNA（ASX:RKT）已获得两项新的自主PatrolBot监视解决方案合同。 PatrolBot是xBot解决方案系列的安全专用型号，提供自主周界监测和监视，确保关键基础设施和资产的安全。合同总价值（TCV）约为350,000澳元。股价上涨22.22%，报0.011美元。
Marquee Resources (ASX:MQR) has identified a significant antimony structural trend with around 220 meters of mineralisation extending from Black Cat Syndicate's (ASX:BC8) Mt Clement deposit. Historical drilling shows significant antimony zones on Marquee's tenure. The company is hopeful that further work will extend known mineralisation and uncover new zones. Shares are trading 18.52 per cent higher at 1.6 cents.
Marquee Resources（ASX:MQR）已确定了一条重要的锑结构趋势，该趋势在从Black Cat Syndicate（ASX:BC8）的Mt Clement矿床延伸约220米的矿化区域。历史钻探显示Marquee矿权区存在重要的锑矿区。公司希望进一步的工作将延伸已知的矿化区域并发现新的矿区。股价上涨18.52%，报0.016美元。
